JPS6233878B2 - - Google Patents
Info
- Publication number
- JPS6233878B2 JPS6233878B2 JP6112084A JP6112084A JPS6233878B2 JP S6233878 B2 JPS6233878 B2 JP S6233878B2 JP 6112084 A JP6112084 A JP 6112084A JP 6112084 A JP6112084 A JP 6112084A JP S6233878 B2 JPS6233878 B2 JP S6233878B2
- Authority
- JP
- Japan
- Prior art keywords
- culture
- suspension
- unit
- cell culture
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000007788 liquid Substances 0.000 claims description 50
- 239000000725 suspension Substances 0.000 claims description 35
- 238000004113 cell culture Methods 0.000 claims description 30
- 239000012510 hollow fiber Substances 0.000 claims description 21
- 239000001963 growth medium Substances 0.000 claims description 18
- 239000012528 membrane Substances 0.000 claims description 17
- 239000002609 medium Substances 0.000 claims description 16
- 235000015097 nutrients Nutrition 0.000 claims description 8
- 239000012466 permeate Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 230000002411 adverse Effects 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 description 41
- 239000000243 solution Substances 0.000 description 35
- 238000000034 method Methods 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 238000012136 culture method Methods 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 239000012736 aqueous medium Substances 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 4
- 238000004114 suspension culture Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000003094 microcapsule Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000012007 large scale cell culture Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- FCASKLHVRFDIJB-UHFFFAOYSA-N Riboflavine Natural products Cc1cc2N=C3C(NC(=O)NC3=O)N(CC(O)C(O)C(O)CO)c2cc1C FCASKLHVRFDIJB-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 210000000628 antibody-producing cell Anatomy 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000011796 hollow space material Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- KUUVQVSHGLHAKZ-UHFFFAOYSA-N thionine Chemical compound C=1C=CC=CSC=CC=1 KUUVQVSHGLHAKZ-UHFFFAOYSA-N 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000008979 vitamin B4 Nutrition 0.000 description 1
- 239000011579 vitamin B4 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
【発明の詳細な説明】
(a) 産業上の利用分野
本発明は細胞を培養増殖させるための培養方法
に関するものである。さらに詳しくは、大規模に
細胞培養を行うに施した方法に関するものであ
り、効率よく細胞に栄養分を与え、一方副生する
生育阻害、物質を除去する目的で作られたサスペ
ンジヨン型細胞培養システムにおける細胞培養方
法に関するものである。
(b) 従来技術
大規模による細胞大量培養は例えばウイルス、
ワクチン、インターフエロンなどの抗ウイルス
剤、あるいはホルモンなどの生物薬品の製造に必
須である。殊に近年特定タンパク質などを標的と
するモノクローナル抗体の生産は抗体産生細胞と
ミエローマによるハイブリドーマ大量培養による
ものであり、その技術の解決は工業的に重要なテ
ーマである。
従来、細胞培養は一般にシヤーレ試験管、培養
びんなどを用いて実験室的規模で行なわれてい
る。
一方近年細胞の大量培養法及びそのための装置
として、いくつかの提案がなされている。これら
の提案は、大きく分けて付着培養(anchorage
dependent culture)と浮遊培養、つまりサスペ
ンジヨン培養(suspension culture)との2つの
方式に分類されるが、これらの方式は培養される
細胞の特性によつていずれかに決められる。
本発明はサスペンジヨン型の細胞培養における
改良方法に関する。そのサスペンジヨン培養によ
つて細胞を培養する方法に関し、最近いくつかの
提案があり、例えばマグネテイツクスターラーも
しくは機械的に駆動されるシヤフト上の羽根車に
よつて、スピナーフラスコの中に調整された撹拌
機能を設けた培養方法などが提案されている(例
えば特開昭57−65180号公報参照)。
しかし上記の方法においては、一定量の栄養分
の中で培養されるため細胞の生長増殖は比較的低
い密度で停止する。
(c) 発明の構成
そこで本発明者らは、前記した如き従来法にお
ける欠点を克服し、サスペンジヨン培養法よつ
て、大量且つ高密度の培養が可能な培養方法につ
いて研究を進めた結果、本発明に到達した。
すなわち、本発明はサスペンジヨン型細胞培養
槽のサスペンジヨン液中に、細胞培養に必要な栄
養分及び生育阻害物質を実質的に透過するが、細
胞は実質的に透過しない壁膜より形成された中空
糸の多数よりなる毛管束であつて、その毛管束の
両端は固着層により固着されたユニツトの少くと
も1個が収納され、(i)サスペンジヨン液中の培養
液をユニツトの中空糸の壁膜を介してユニツトの
両端又は一端から導管を通じて培養槽外へ排出
し、(ii)しかる後、培養槽外から細胞培養に悪影響
を与えない水性液体媒体を導管を通じて該ユニツ
トの両端又は一端へ供給して該液体媒体を中空糸
の壁膜を介してサスペンジヨン液中へ流入し、前
記排出と流入とを交互に繰返すことを特徴とする
細胞培養方法である。
さらに前記本発明方法は、サスペンジヨン型細
胞培養槽のサスペンジヨン液中に、少くとも2個
の該ユニツトが収納され、それぞれのユニツトは
前記排出と流入が交互に繰返されるように作動さ
れ、且つ該培養槽中のサスペンジヨン液中の培養
液の排出が停止しないように各ユニツトの排出と
流入の間隔を互いに制御することによつて一層有
利に培養することができる。
かくして本発明の培養方法によれば、サスペン
ジヨン型の培養槽におけるサスペンジヨン液中
に、少くとも1個の前記毛管束よりなるユニツト
が沈められており、細胞が産出した老廃物、代謝
産物、その他生育阻害物質を含んだ古い培養液
が、サスペンジヨン液から中空糸の壁膜を介して
中空糸中へ流れユニツトの両端又は一端から導管
を経て培養槽外へ排出され、或る時間経過すると
この排出を停止し、次いで培養槽外から細胞培養
に悪影響を与えない水性液体媒体を導管を通じて
ユニツトの両端又は一端へ供給して該液体媒体を
中空糸の壁膜を介してサスペンジヨン液へ流入せ
しめられる。
従つて、本発明方法においては、サスペンジヨ
ン液中に沈められたユニツトによつて、それに設
けられた多数の中空糸の壁膜を介して水性液体媒
体のサスペンジヨン液中への供給と、サスペンジ
ヨン液中からの古い培養液へ排出とが交互に繰返
されるので、中空糸の壁膜の細孔に細胞やその他
固形物が詰り実質的な壁面積の効率低下を来すこ
とはなく、有利に水性液体媒体の供給と、古い培
養液の排出とをスムースに行うことができ、極め
て高密度の細胞培養が可能となる。
特に本発明方法においては、ユニツトを2個以
上別々に或いは適当に組合せてサスペンジヨン液
中に浸入することもでき、また簡単に2個以上を
直列又は並列に連結して使用することもできるの
で、細胞の種類と密度、培養条件、培養の規模の
変化に応じて容易に中空糸の壁膜の面積を適応さ
せることが可能である。
また本発明においては、少くとも2個のユニツ
トの組合せて使用し、それぞれのユニツトは、培
養槽のサスペンジヨン液中において液の供給と古
い培養液の排出が繰返されるように作動され、且
つ少くとも1個のユニツトは古い培養液の排出が
常時行なわれるように、つまり培養槽中のサスペ
ンジヨン液中の培養液の排出が停止しないように
各ユニツトにおける液の排出と流入の間隔を互い
に制御することができる。
本発明の細胞培養方法はサスペンジヨン型の細
胞培養に適用されるが、サスペンジヨン型とは、
水性媒体中で細胞それ自体が浮遊しながら、或い
は細胞を微小担体(マイクロキヤリアー)に担持
して浮遊しながら、またマイクロカプセル中で細
胞が生育されるような種々の浮遊培養をいう。殊
に本発明は、細胞自体を浮遊させながら培養する
方式に有利に用いられる。
本発明の細胞培養方法において培養される細胞
は、植物細胞、動物細胞、微生物細胞などであつ
てもよく、また人為的或いは遺伝子操作により変
性された細胞であつてもよい。殊に本発明の培養
方法は、動物細胞の培養に適している。
本発明におけるサスペンジヨン型の細胞培養槽
中においては、培養しようとする細胞が培養液中
に浮遊した状態で培養される。培養液は実質的に
水よりなる水性媒体に、種々の無機塩、ビタミン
類、捕酵素、ブドウ糖、アミノ酸、抗生物質など
の通常細胞培養に使用される添加成分が加えられ
ている。また培養液には血清を加えることもでき
るし、血清を用いない所謂無血清培地を培養液と
して使用することも出来る。
本発明方法において、培養槽外からサスペンジ
ヨン液中にあるユニツトへ導管を通じて供給され
る“細胞培養に悪影響を与えない水性媒体”とし
ては、減菌水を主体としてこの中に前記添加成分
の一種又はそれ以上を加えて使用することができ
る。この水性媒体は培養に必要な全ての添加成分
を含んでいる新しい培養液であつてもよく、また
これら成分を全て含んでいる必要はなく、一部は
他の供給手段でサスペンジヨン液中に導入するこ
ともできる。また水性媒体としては、本発明方法
に従つてユニツトから導管を通じて培養槽外へ排
出された培養液(以下これを“古い培養液”とい
うことがある)を一部として使用することも可能
である。
本発明方法に使用されるユニツトを構成してい
る中空糸毛管は、種々の重合体よりなるものであ
ればよく、その重合体としては例えばセルロース
アセテート、ポリスルホン、ポリアクリロニトリ
ル、弗素系ポリマーなどが好ましい例として挙げ
られる。
中空糸毛管の壁膜には多数の微細孔を有してお
り、その毛管の壁膜は、栄養分及び細胞の老廃
物、代謝生産物などを透過するが、細胞或いはそ
れが付着した微小担体又はマイクロカプセルは透
過しない大きさの細孔が多数設けられている。細
胞自体を浮遊させて培養させる場合、細孔の大き
さは細胞の大きさによつて左右されるが、一般に
平均孔径が10μ以下、好ましくは8μ以下が適当
である。一方微小担体(マイクロキヤリアー)の
表面に細胞を付着させて培養させる場合又はマイ
クロカプセルを使用して培養させる場合には、そ
れらが透過しない大きさの細孔である必要があ
る。
また、該毛管の壁膜は、水を或る程度透過する
能力を有することが望ましい。すなわち、該壁膜
は水の透過係数(ml/m2・hr・mmHg)が10以
上、好ましくは100以上であるのが有利である。
一方上限は特にないが、20000以下、好ましくは
10000以下が望ましい。
さらに該壁膜としては、栄養分や細胞の老廃
物、代謝生産物などの如き分子量の小さい化合物
は透過するが、分子量の大きい化合物(例えば
1000以上、好ましくは5000以上)は透過しない
膜、例えば限外濾過膜を使用することも可能であ
る。
以下添付図面により本発明の細胞培養装置を更
に詳細に説明する。
添付第1図は、本発明の細胞培養方法を実施す
るための概略図の一例を示すものであり、第2−
A図、第2−B図及び第2−C図はそれぞれ本発
明におけるユニツトの概略図の一例を示したもの
である。
第1図は、2つのユニツト3−a及び3−bを
一対として作動させて培養する場合を示したもの
であり、第1図において、1はサスペンジヨン型
培養槽における培養本体であり、栄養物などを含
む水性媒体は、その供給槽6からポンプ7により
供給導管8を通り切り換え弁12又は14を経て
一つのユニツトへ送られる。一方他のユニツトか
らは古い培養液が排出され切り換え弁13又は1
5を経て排出導管11を通つてポンプ10により
古い培養液の貯槽9へ送られる。
第1図に示されている2つのユニツト3−a及
び3−bは、多数の中空糸よりなる毛管束の両端
は固着層により固着されている。そしてその上部
は液の流出入口になつており、その下部は封止さ
れている構造を有している。
培養槽1には、細胞がサスペンジヨン液中を効
果的に浮遊するように撹拌装置2が第1図に示す
ように備え付けられていてもよい。撹拌2のよう
に回転型撹拌翼に限らずマグネツトスターラーで
あつてもよい。さらにサスペンジヨン液中の細胞
を効果的に浮遊させることができる他の撹拌効果
を奏する手段であつてもよい。
第1図の培養槽においては2つのユニツトが一
対となつている一つの組の場合について示されて
いるが、この一対の組は一つに限らず複数組使用
することもできる。またユニツトは一対の組とし
て使用しないで、一個の独立したユニツトを入れ
このユニツトに培養液の排出と水性液体媒体の供
給とを繰返して操作するようにしてあつてもよ
い。この独立したユニツトを多数使用することが
できることは云うまでもない。
さらに培養槽には、酸素、二酸化炭素や栄養素
の濃度、PHの値を測定し、それらを或る範囲に維
持する装置が一般に設置されているが、本発明の
細胞培養槽にもこれらの装置が備えられてもよい
ことは云うまでもない。しかし第1図にはこれら
の付属装置は省略されている。
本発明の培養槽に供給される新しい培養液は、
この中にブドウ等、蛋白質の如き栄養源、種々ア
ミノ酸、無機質、抗生物質などの細胞培養に必要
な成分を水溶液として含むものが使用されるが、
さらに血清を含んでいてもよく、また含んでいな
くてもよい。これら成分は必要な全てを培養液と
してユニツトを通して供給してもよいが、一部の
成分は他の供給手段によつてサスペンジヨン液中
へ導入することも可能である。一般に細胞培養に
は、酸素、二酸化炭素なども必要であるが、これ
らは新しい培養液に溶存させて供給してもよく、
さらに第1回に示すように弁16を通してガス供
給管17より直接サスペンジヨン液へ供給しても
よい。
第2−A図、第2−B図及び第2−C図はいず
れも本発明方法に使用されるユニツトの種々の形
態の例を示したものである。これらの図において
矢印→は第1図の培養槽において切り換え弁1
2,13,14又は15のいずれかに接続される
液の流出入口に結合した導管を示している。
第2−A図のユニツトは基本的には、第1図の
ユニツトと同じ形態のものであり、多数の中空糸
よりなる毛管束の両端が固着層により固着され、
一方の端部に液の共通した流入口と排出口が設け
られており、他の端部は封止された構造を有して
いる。第2−B図は毛管束の両端が固着層に固着
され、その両端には液の出入口が設けられ、この
出入口にはそれぞれ導管が結合され、これら導管
が結合されて共通した液の流入口と排出口を形成
している構造を有している。また第2−C図は毛
管束の両端が1つの共通した固着層によつて固着
された形態であり、その両端部に液の共通した流
入口と排出口を有している構造を有している。以
上それぞれのユニツトは、基本的な型の一例を示
したものであり、他の若干の変更は当然許容され
る。これらユニツトは任意に複数個組合せて使用
することもできる。
本発明方法において1つのユニツトは、いずれ
も水性液状媒体(例えば新しい培養液)の供給と
古い培養液の排出とを交互に繰返しながら操作さ
れるが、その間隔は、細胞の種類、密度、培養条
件などによつて左右されるが、一般には1分乃至
1日、好ましくは5分乃至10時間の範囲で切り換
えることが出来る。
本発明方法は1つのユニツトをサスペンジヨン
液中に沈めて前述のように液の供給と排出を交互
に繰返しながら操作することもでき、またこのよ
うに操作されるユニツトを2個以上沈めてそれぞ
れ独立して操作してもよい。
しかしながら一般には2個又はそれ以上のユニ
ツトを使用するのが好ましく、その場合複数のユ
ニツトを互いに連動させて操作するのが有利であ
る。
複数のユニツトを互いに連動させて操作する場
合、培養槽におけるサスペンジヨン液の培養液の
槽外への排出が一時期においても停止することが
ないように(つまり常時古い培養液の槽外への排
出が行なわれるように)各ユニツトの液の排出と
流入の間隔を互いに制御するのが一層望ましい。
また2個のユニツトを一対としてサスペンジヨン
液中へ沈め、その一方は水性液体媒体がサスペン
ジヨン液中へ供給され、他のユニツトは古い培養
が排出されるように作動しており、それらの流れ
が交互に逆になるように切り換え弁を切り換える
ように操作してこのように一対のユニツトを交互
に作動させることにより水性液体媒体の供給と、
古い培養液の排出とを常時連続的に行い、かくし
て、しかも培養槽中のサスペンジヨンの液面を一
定の水準に維持することが容易に可能となる。
本発明方法を実施するに当つて、或るユニツト
における水性液体媒体の供給と古い培養液の排出
との間隔は任意に決定することができる。一般に
は古い培養液の排出は、細胞などが中空糸の壁膜
の細孔を塞ぎ排出量が少なくならない限り長時間
行うことができるが、30分以上10日以内が望まし
く、サスペンジヨン液中の細胞密度が小さいとき
は比較的長時間であり、逆に細胞密度が大きくな
ると短時間になる傾向がある。
一方水性液体媒体(例えば新しい培養液)の供
給は、前記排出よりも概して短い時間でよい。普
通1分以上であれば充分である。供給時間は供給
量(面積当り)によつても左右され、多いと短か
くてよい。逆に少ないと長くすることが必要とな
る。特に若干加圧して短時間に水性液体媒体を供
給することが有利であることが多い。
以上説明した本発明の培養方法によれば、サス
ペンジヨン型の培養において、新しい培養液の供
給と古い培養液の排出を連続的或いは半連続的に
行うので、高密度でしかも大量の細胞を培養する
ことが出来る。殊に本発明ではユニツトにおける
中空糸の壁膜の細胞に細胞その他の固形物が一時
的に詰つたとしても、長時間に亘つて詰ることは
なく、従つて効果的に培養液の交換を行うことが
出来、極めて高密度の培養を行うことが可能であ
る。
さらに本発明のユニツトは、単に2個以上或い
はこれを直列又は並列、或いは独立して2本以上
を適当に組合せて、装置の規模、細胞の種類、培
養条件などに合せながら使用することが容易であ
るという利点がある。
以下実施例を掲げて本発明方法を詳述する。
実施例
(1) ユニツトの性状;
セルローズアセテート、アクリル酸ポリマー
及び硝酸セルロースよりなるポリマーアロイよ
り形成された中空糸の多数を用いて、添付図面
第2−A図に示されるような片側が封止された
ユニツトを作つた。各中空糸の内径は320μで
あり外径は460μであつて、その壁膜は平均孔
径が0.2μの多数の微細孔を有していた。ユニ
ツトにおける中空糸の有孔長は36mmであり、中
空糸の総有効面積(外径基準)は80cm2であつ
た。なお使用した中空糸の透水率は4/m2・
hr・mmHgであつた。
(2) 培養槽の形状;
添付第1図に示したような構造をした内容積
が500mlのガラス容器を培養積として使用し
た。この培養槽には、第1図に示されているよ
うに2つのユニツトが収納されており、またマ
リン型撹拌子が装着されている。
また、培養槽内には二酸化炭素及び酸素の供
給導管が挿入されているが、これは第1図の5
に該当する。
(3) 新培養液組成;
使用した新しい培養液の組成は下記の通りで
あつた。
単位は特に断わらない限り1当りのmM
(ミリモル)である。
NaCl 110.0mM
KCl 5.0
MgSO4 0.55
MgCl2・6H2O −
Ca(NO3)2・4H2O −
CaCl2・2H2O 0.74
NaH2PO4・2H2O −
Na2HPO4・12H2O 3.41
CuSO・5H2O 3.0×10-6
FeSO4・7H2O 8.0×10-4
Fe(NO3)3・9H2O −
ZnSO4・7H20 8.0×10-4
Alanine 0.075
Arginine・HCl 2.76
Asparagine・H2O 0.63
Asparatic acid 0.30
Cysteine・HCl・H2O 0.60
Cystine −
Glutamic acid 0.27
Glutamine 6.84
Glycine 0.57
Histidine・HCl・H2O 0.36
Hydroxyproline 0.24
Isoleucine 1.20
Lecine 1.26
Lysine・HCl 1.08
Methionine 0.33
Phenylalanine 0.45
Proline 0.48
Serine 0.81
Threonine 0.93
Tryptophan 0.09
Tyrosine 0.48
Valine 0.93
p−Amino benzoic acid 3.7×10-3
Biotin 4.1×10-4
Pantothenate−Ca 2.6×10-3
Cholin chloride 8.8×10-2
Folic acid 4.1×10-3
Inositol 2.6×10-1
Niacinamide 1.2×10-2
Pyridoxal・HCl 4.9×10-3
Pyridoxine・HCl 2.5×10-3
Riboflavine 5.6×10-4
Thiamin・HCl 4.7×10-3
Vitamin B12 2.5×10-4
Lipoic acid 2.5×10-4
Glutathicne 1.6×10-3
Glucose 19.00
Hypoxanthine 7.5×10-3
Putrescine・2HCl 2.5×10-4
Pyruvate−Na 1.0
Thymidine 7.5×10-3
Linoleic acid 7.5×10-5
Phenol red 5.0mg/L
HEPES 1.19g/L
NaHCO3 12.50mM
Streptomycin 0.1g/L
Penicillin G 10-5U/L
Insuline 7.5μg/ml
Transphclin 2μg/ml
Ethanolamine 10μM/L
Na2SeO3 2.5×10-9M/L
(4) 培養方法;
前記培養槽に液容積が300mlとなるように新
しい培溶液を入れその中に2つのユニツトを挿
入した。それぞれのユニツトは第1図の6に示
すような新しい培養液供給槽と、古い培養液の
貯槽9とに切り換え弁を介して、それぞれ導管
で結合されている。それぞれの導管の途中に
は、ポンプが設けられており、2つのユニツト
は切り換え弁によつて一方のユニツトが新しい
培養液を培養槽に供給している時には、他のユ
ニツトは古い培養液が槽外へ排出されるように
互に逆の流れをするようになつている。
一方培養槽においてはCO2ガス及びO2ガスが
サスペンジヨン液中へ供給され、それらの供給
はそれぞれ系内のPH6.5〜7、溶存酸素量が3
〜4ppmの一定となるように制御された。
培養槽の培養液中にマウスミエローマ細胞
p3u1を親株とするマウスハイブリドーマ
4C10B6細胞株を1×10.5個/mlとなるように
加えた。この細胞は免疫グロブリン(IgG)生
産型の株である。
培養中のサスペンジヨン液は27℃に保持さ
れ、またマリン型撹拌子は60rpmの速度で回転
させた。培養開始後、細胞密度が1×106個/
mlになつてから2つのユニツトの作動を開始
し、新しい培養液の供給と古い培養液の排出を
行つた。1つのユニツトにおける供給と排出の
間隔はほゞ12時間単位で行い、1日における新
しい培養液の培養槽への供給は約300mlであつ
た。しかし培養開始後5日経過後は、この新し
い培養液の供給を1日当り最高500mlまで徐々
に増加させた。
(5) 培養結果;
かくして9日間培養を行つた結果は下記の通
りであつた。
なお本発明のユニツトを全く使用しない他は
全く同一条件で培養を行つた時の最終の細胞密
度は2×106個/mlであつた。
【表】DETAILED DESCRIPTION OF THE INVENTION (a) Industrial Application Field The present invention relates to a culture method for culturing and propagating cells. More specifically, it relates to the method used for large-scale cell culture, and is a suspension-type cell culture system designed to efficiently provide nutrients to cells while removing by-product growth inhibitors and substances. This invention relates to a cell culture method. (b) Prior art For example, large-scale cell culture using viruses,
It is essential for the production of vaccines, antiviral agents such as interferon, and biological drugs such as hormones. Particularly in recent years, the production of monoclonal antibodies targeting specific proteins has been based on mass culturing of hybridomas using antibody-producing cells and myeloma, and solving this technology is an industrially important theme. Conventionally, cell culture has generally been carried out on a laboratory scale using Schare test tubes, culture bottles, and the like. On the other hand, in recent years, several proposals have been made regarding mass culture methods for cells and devices for the same. These proposals can be broadly divided into attached culture (anchorage culture).
Cell culture is classified into two types: dependent culture and suspension culture, and one of these methods is determined depending on the characteristics of the cells to be cultured. The present invention relates to an improved method for suspension-type cell culture. There have been several recent proposals on how to culture cells by suspension culture, for example by means of a magnetic stirrer or an impeller on a mechanically driven shaft, arranged in a spinner flask. Culture methods equipped with a stirring function have been proposed (for example, see Japanese Patent Application Laid-open No. 1983-65180). However, in the above method, since the cells are cultured in a fixed amount of nutrients, the growth and proliferation of cells stops at a relatively low density. (c) Structure of the Invention Therefore, the present inventors overcame the drawbacks of the conventional methods as described above and conducted research on a culture method that enables large-scale and high-density culture using the suspension culture method, and as a result, the present invention was developed. invention has been achieved. That is, the present invention provides a suspension liquid in a suspension-type cell culture tank with a hollow space formed by a wall membrane that substantially permeates nutrients and growth-inhibiting substances necessary for cell culture, but does not substantially permeate cells. A capillary bundle consisting of a large number of threads, in which at least one unit is fixed by a fixing layer is housed at both ends of the capillary bundle, and (i) the culture solution in the suspension solution is transferred to the walls of the hollow fibers of the unit. (ii) After that, an aqueous liquid medium that does not adversely affect the cell culture is supplied from outside the culture tank to both ends or one end of the unit through the conduit. This cell culture method is characterized in that the liquid medium is then allowed to flow into the suspension liquid through the wall membrane of the hollow fiber, and the above-mentioned discharge and inflow are repeated alternately. Furthermore, in the method of the present invention, at least two of the units are housed in the suspension liquid of a suspension type cell culture tank, and each unit is operated so that the discharge and inflow are alternately repeated; More advantageous cultivation can be achieved by mutually controlling the intervals between discharge and inflow of each unit so that the discharge of the culture solution in the suspension solution in the culture tank does not stop. Thus, according to the culture method of the present invention, a unit consisting of at least one capillary bundle is submerged in a suspension liquid in a suspension-type culture tank, and waste products, metabolites, and The old culture solution containing other growth-inhibiting substances flows from the suspension solution into the hollow fiber through the wall membrane of the hollow fiber, and is discharged from both ends or one end of the unit to the outside of the culture tank via a conduit, and after a certain period of time has passed. This discharge is stopped, and then an aqueous liquid medium that does not adversely affect the cell culture is supplied from outside the culture tank to both ends or one end of the unit through the conduit, and the liquid medium flows into the suspension liquid through the hollow fiber wall membrane. I am forced to do it. Therefore, in the method of the present invention, the unit submerged in the suspension liquid supplies an aqueous liquid medium into the suspension liquid through the wall membrane of a large number of hollow fibers provided therein, and Since the drainage from the John's solution to the old culture solution is repeated alternately, the pores of the hollow fiber wall membrane will not be clogged with cells or other solids, which will result in a substantial decrease in wall area efficiency, which is advantageous. It is possible to smoothly supply an aqueous liquid medium and to drain old culture medium, making it possible to culture cells at an extremely high density. In particular, in the method of the present invention, two or more units can be immersed into the suspension liquid separately or in a suitable combination, and two or more units can be easily connected in series or in parallel for use. , it is possible to easily adapt the wall area of the hollow fiber according to changes in cell type and density, culture conditions, and culture scale. In addition, in the present invention, at least two units are used in combination, and each unit is operated so that the suspension liquid of the culture tank is repeatedly supplied with the liquid and the old culture liquid is discharged. In both units, the intervals between the draining and inflowing of the liquid in each unit are mutually controlled so that the old culture medium is constantly drained, that is, the draining of the culture medium in the suspension liquid in the culture tank does not stop. can do. The cell culture method of the present invention is applied to suspension type cell culture.
It refers to various types of suspension culture in which cells are grown in an aqueous medium while floating themselves, while floating on microcarriers, or in microcapsules. In particular, the present invention is advantageously used in a system in which the cells themselves are cultured while being suspended. The cells cultured in the cell culture method of the present invention may be plant cells, animal cells, microbial cells, etc., or cells that have been modified artificially or by genetic manipulation. In particular, the culture method of the present invention is suitable for culturing animal cells. In the suspension-type cell culture tank of the present invention, cells to be cultured are cultured in a suspended state in a culture solution. The culture solution is an aqueous medium consisting essentially of water, to which are added additives commonly used in cell culture, such as various inorganic salts, vitamins, enzyme traps, glucose, amino acids, and antibiotics. Further, serum can be added to the culture solution, or a so-called serum-free medium that does not use serum can also be used as the culture solution. In the method of the present invention, the "aqueous medium that does not adversely affect cell culture" that is supplied from outside the culture tank to the unit in the suspension liquid through a conduit is mainly sterile water, in which one of the above-mentioned additives is added. or more can be used. This aqueous medium may be a fresh culture medium containing all the additional components necessary for the culture, and need not contain all of these components, some of which may be added to the suspension solution by other means of supply. It can also be introduced. Furthermore, as the aqueous medium, it is also possible to use part of the culture solution (hereinafter sometimes referred to as "old culture solution") discharged from the unit to the outside of the culture tank through the conduit according to the method of the present invention. . The hollow fiber capillary constituting the unit used in the method of the present invention may be made of various polymers, and preferred examples of such polymers include cellulose acetate, polysulfone, polyacrylonitrile, and fluorine-based polymers. Examples include: The wall of the hollow fiber capillary has many micropores, and the wall of the capillary is permeable to nutrients, cell waste products, metabolic products, etc. Microcapsules are provided with many pores that are sized to prevent penetration. When the cells themselves are cultured in suspension, the size of the pores depends on the size of the cells, but generally an average pore size of 10 μm or less, preferably 8 μm or less is suitable. On the other hand, when cells are cultured by adhering to the surface of microcarriers (microcarriers) or when cells are cultured using microcapsules, the pores need to be of a size that does not allow them to pass through. It is also desirable that the capillary wall membrane has the ability to permeate water to some extent. That is, it is advantageous for the wall membrane to have a water permeability coefficient (ml/m 2 ·hr · mmHg) of 10 or more, preferably 100 or more.
On the other hand, there is no particular upper limit, but 20,000 or less, preferably
Desirably 10000 or less. Furthermore, as the wall membrane, compounds with a small molecular weight such as nutrients, cellular waste products, and metabolic products permeate, but compounds with a large molecular weight (e.g.
1000 or more, preferably 5000 or more), it is also possible to use a membrane that does not pass, such as an ultrafiltration membrane. The cell culture device of the present invention will be explained in more detail below with reference to the accompanying drawings. The attached FIG. 1 shows an example of a schematic diagram for carrying out the cell culture method of the present invention, and FIG.
Figure A, Figure 2-B, and Figure 2-C each show an example of a schematic diagram of a unit in the present invention. Fig. 1 shows the case where two units 3-a and 3-b are operated as a pair for culturing. In Fig. 1, 1 is the culture main body in a suspension type culture tank, The aqueous medium containing substances is sent from its supply tank 6 by means of a pump 7 through a supply conduit 8 and via a switching valve 12 or 14 to one unit. On the other hand, the old culture solution is discharged from the other unit and the switching valve 13 or 1
5 and through a discharge conduit 11 by means of a pump 10 to a storage tank 9 for old culture medium. In the two units 3-a and 3-b shown in FIG. 1, both ends of a capillary bundle consisting of a large number of hollow fibers are fixed by a fixed layer. The upper part serves as a liquid inlet and outlet, and the lower part has a sealed structure. The culture tank 1 may be equipped with a stirring device 2 as shown in FIG. 1 so that the cells are effectively suspended in the suspension liquid. It is not limited to a rotary stirring blade as in stirring 2, but a magnetic stirrer may also be used. Furthermore, other stirring effects that can effectively suspend the cells in the suspension liquid may be used. Although the culture tank shown in FIG. 1 is shown in one set in which two units are paired, the number of pairs is not limited to one, and a plurality of sets may also be used. Alternatively, the units may not be used as a pair, but a single independent unit may be used to repeatedly discharge the culture solution and supply the aqueous liquid medium to this unit. It goes without saying that a large number of these independent units can be used. Furthermore, culture tanks are generally equipped with devices that measure oxygen, carbon dioxide, nutrient concentrations, and PH values and maintain them within certain ranges, and the cell culture tank of the present invention also incorporates these devices. Needless to say, it may be provided. However, these accessories are omitted from FIG. The new culture solution supplied to the culture tank of the present invention is
Among these, grapes and other materials containing nutrients such as proteins, various amino acids, minerals, antibiotics, and other components necessary for cell culture are used as an aqueous solution.
Furthermore, it may or may not contain serum. All of these components may be supplied through the unit as a culture solution, but some components may also be introduced into the suspension solution by other supply means. Generally, cell culture requires oxygen, carbon dioxide, etc., but these may be supplied dissolved in the new culture medium.
Further, as shown in the first example, the suspension liquid may be directly supplied from the gas supply pipe 17 through the valve 16. Figures 2-A, 2-B and 2-C all show examples of various forms of units used in the method of the present invention. In these figures, the arrow → indicates the switching valve 1 in the culture tank in Figure 1.
2, 13, 14, or 15, the conduit is connected to a liquid inlet or outlet. The unit shown in FIG. 2-A is basically of the same form as the unit shown in FIG.
A common liquid inlet and outlet are provided at one end, and the other end has a sealed structure. In Figure 2-B, both ends of the capillary bundle are fixed to the fixed layer, liquid inlets and outlets are provided at both ends, conduits are connected to each of these inlets and outlets, and these conduits are connected to form a common liquid inlet. It has a structure that forms a discharge port. Furthermore, Fig. 2-C shows a structure in which both ends of the capillary bundle are fixed by one common fixing layer, and both ends have a common inlet and outlet for liquid. ing. Each of the units described above is an example of a basic type, and other slight changes are of course allowed. A plurality of these units can be used in any combination. In the method of the present invention, one unit is operated while alternately supplying an aqueous liquid medium (for example, fresh culture medium) and draining old culture medium, and the intervals are determined depending on the cell type, density, and culture. Although it depends on the conditions, it can generally be switched within a range of 1 minute to 1 day, preferably 5 minutes to 10 hours. The method of the present invention can also be operated by submerging one unit in the suspension liquid and alternately repeating the supply and discharge of the liquid as described above, or by submerging two or more units to be operated in this way and submerging each unit. May be operated independently. However, it is generally preferred to use two or more units, in which case it is advantageous to operate the units in conjunction with one another. When operating multiple units in conjunction with each other, make sure that the suspension solution in the culture tank does not stop discharging the culture solution to the outside of the tank (in other words, the old culture solution is constantly drained to the outside of the tank). It is more desirable to mutually control the intervals between the discharge and inflow of liquid in each unit so that the liquid discharge and inflow of each unit are carried out.
In addition, two units are submerged in the suspension liquid as a pair, one of which is operated to supply an aqueous liquid medium into the suspension liquid, and the other unit is operated so that old culture is discharged, and their flow is controlled. Supplying an aqueous liquid medium by operating the pair of units alternately in this way by switching the switching valve so that the values are alternately reversed;
The old culture solution can be continuously drained at all times, and the liquid level of the suspension in the culture tank can be easily maintained at a constant level. In carrying out the method of the invention, the interval between the supply of aqueous liquid medium and the discharge of old culture medium in a given unit can be arbitrarily determined. In general, old culture solution can be drained for a long time as long as cells etc. do not block the pores of the hollow fiber wall membrane and reduce the amount of discharge, but it is preferable to drain the old culture solution for at least 30 minutes and within 10 days. When the cell density is low, the time is relatively long, and when the cell density is high, the time tends to be short. On the other hand, supplying an aqueous liquid medium (eg fresh culture medium) generally takes less time than said draining. Generally, 1 minute or more is sufficient. The supply time also depends on the supply amount (per area), and the longer it is, the shorter it is. On the other hand, if it is too small, it will be necessary to make it longer. In particular, it is often advantageous to supply the aqueous liquid medium over a short period of time under slight pressure. According to the culture method of the present invention described above, in suspension-type culture, supply of new culture medium and draining of old culture medium are performed continuously or semi-continuously, so that a large number of cells can be cultured at high density. You can. In particular, in the present invention, even if the cells in the wall membrane of the hollow fibers in the unit are temporarily clogged with cells or other solid matter, the clogging will not occur for a long time, and therefore the culture medium can be exchanged effectively. It is possible to perform extremely high-density culture. Furthermore, the units of the present invention can be easily used by simply combining two or more units, in series or parallel, or by combining two or more units independently to suit the scale of the device, cell type, culture conditions, etc. It has the advantage of being The method of the present invention will be described in detail below with reference to Examples. Example (1) Properties of the unit; One side is sealed as shown in Figure 2-A of the attached drawings using a large number of hollow fibers formed from a polymer alloy consisting of cellulose acetate, acrylic acid polymer, and cellulose nitrate. I created a unit that was The inner diameter of each hollow fiber was 320μ and the outer diameter was 460μ, and the wall membrane had many micropores with an average pore diameter of 0.2μ. The perforated length of the hollow fibers in the unit was 36 mm, and the total effective area (based on the outer diameter) of the hollow fibers was 80 cm 2 . The water permeability of the hollow fiber used was 4/m 2 .
It was hr・mmHg. (2) Shape of the culture tank; A glass container with an internal volume of 500 ml and having the structure shown in attached Figure 1 was used as the culture volume. This culture tank houses two units as shown in FIG. 1, and is also equipped with a marine type stirrer. In addition, carbon dioxide and oxygen supply pipes are inserted into the culture tank, but these are 5 in Figure 1.
Applies to. (3) Composition of new culture solution: The composition of the new culture solution used was as follows. Units are 1mM unless otherwise specified.
(millimol). NaCl 110.0mM KCl 5.0 MgSO 4 0.55 MgCl 2・6H 2 O − Ca(NO 3 ) 2・4H 2 O − CaCl 2・2H 2 O 0.74 NaH 2 PO 4・2H 2 O − Na 2 HPO 4・12H 2 O 3.41 CuSO・5H 2 O 3.0×10 -6 FeSO 4・7H 2 O 8.0×10 -4 Fe(NO 3 ) 3・9H 2 O − ZnSO 4・7H 2 0 8.0×10 -4 Alanine 0.075 Arginine・HCl 2.76 Asparagine・H 2 O 0.63 Asparatic acid 0.30 Cysteine・HCl・H 2 O 0.60 Cystine − Glutamic acid 0.27 Glutamine 6.84 Glycine 0.57 Histidine・HCl・H 2 O 0.36 Hydroxyproline 0.24 Isoleucine 1.20 Lecine 1.26 Lysine・HCl 1.08 Me Thionine 0.33 Phenylalanine 0.45 Proline 0.48 Serine 0.81 Threonine 0.93 Tryptophan 0.09 Tyrosine 0.48 Valine 0.93 p-Amino benzoic acid 3.7×10 -3 Biotin 4.1×10 -4 Pantothenate−Ca 2.6×10 -3 Cholin chloride 8.8×10 -2 Folic acid 4.1×10 -3 Inositol 2.6 ×10 -1 Niacinamide 1.2×10 -2 Pyridoxal・HCl 4.9×10 -3 Pyridoxine・HCl 2.5×10 -3 Riboflavine 5.6×10 -4 Thiamin・HCl 4.7×10 -3 Vitamin B 12 2.5×10 -4 Lipoic acid 2.5×10 -4 Glutathicne 1.6×10 -3 Glucose 19.00 Hypoxanthine 7.5×10 -3 Putrescine・2HCl 2.5×10 -4 Pyruvate−Na 1.0 Thymidine 7.5×10 -3 Linoleic acid 7.5×10 -5 Phenol red 5.0mg/L HEPES 1.19g/L NaHCO 3 12.50mM Streptomycin 0.1g/L Penicillin G 10 -5 U/L Insuline 7.5μg/ml Transphclin 2μg/ml Ethanolamine 10μM/L Na 2 SeO 3 2.5×10 -9 M/L (4) Cultivation method: A new culture solution was put into the culture tank so that the liquid volume was 300 ml, and two units were inserted into it. Each unit is connected to a new culture solution supply tank as shown at 6 in FIG. 1 and to an old culture solution storage tank 9 via a conduit via a switching valve. A pump is installed in the middle of each conduit, and the two units are operated by switching valves so that when one unit is supplying new culture solution to the culture tank, the other unit is supplying old culture solution to the tank. They are designed to flow in opposite directions so that they are discharged to the outside. On the other hand, in the culture tank, CO 2 gas and O 2 gas are supplied into the suspension liquid, and these supplies are applied to the system pH 6.5 to 7 and the amount of dissolved oxygen to 3.
Controlled to a constant ~4ppm. Mouse myeloma cells in the culture medium of the culture tank
Mouse hybridoma with p3u1 as the parent strain
4C10B6 cell line was added at 1 x 10.5 cells/ml. This cell is an immunoglobulin (IgG) producing strain. The suspension solution during culture was maintained at 27°C, and a marine type stirrer was rotated at a speed of 60 rpm. After starting the culture, the cell density is 1×10 6 cells/
ml, we started operating the two units, supplying new culture medium and draining old culture medium. The feeding and draining intervals in one unit were approximately every 12 hours, and approximately 300 ml of fresh culture solution was fed to the culture tank per day. However, after 5 days from the start of culture, the supply of this new culture medium was gradually increased to a maximum of 500 ml per day. (5) Culture results: The results of culturing for 9 days were as follows. The final cell density was 2 x 106 cells/ml when culturing was carried out under exactly the same conditions except that no unit of the present invention was used. 【table】
第1図は本発明の細胞培養方法を実施するため
の概略図の一例を示したものであり、第2−A
図、第2−B図及び第2−C図は、それぞれ本発
明の細胞培養方法に用いられるユニツトの形態の
例を示したものである。
FIG. 1 shows an example of a schematic diagram for carrying out the cell culture method of the present invention, and FIG.
2-B and 2-C respectively show examples of the form of the unit used in the cell culture method of the present invention.
Claims (1)
ン液中に、細胞培養に必要な栄養分及び生育阻害
物質を実質的に透過するが、細胞は実質的に透過
しない壁膜より形成された中空糸の多数よりなる
毛管束であつて、その毛管束の両端は固着層によ
り固着されたユニツトの少くとも1個が収納さ
れ、(i)サスペンジヨン液中の培養液をユニツトの
中空糸の壁膜を介してユニツトの両端又は一端か
ら導管を通じて培養槽外へ排出し、(ii)しかる後、
培養槽外から細胞培養に悪影響を与えない水性液
体媒体を導管を通じて該ユニツトの両端又は一端
へ供給して該液体媒体を中空糸の壁膜を介してサ
スペンジヨン液中へ流入し、前記排出と流入とを
交互に繰返すことを特徴とする細胞培養方法。 2 サスペンジヨン型細胞培養槽のサスペンジヨ
ン液中に、少くとも2個の該ユニツトが収納さ
れ、それぞれのユニツトは前記排出と流入が交互
に繰返されるように作動され、且つ該培養槽中の
サスペンジヨン液中の培養液の排出が停止しない
ように各ユニツトの排出と流入の間隔を互いに制
御することを特徴とする第1項記載の細胞培養方
法。[Scope of Claims] 1. The suspension solution of a suspension-type cell culture tank is formed of a wall membrane that substantially permeates nutrients and growth-inhibiting substances necessary for cell culture, but does not substantially permeate cells. A capillary bundle consisting of a large number of hollow fibers, each end of which is housed with at least one unit fixed by a fixed layer, and (i) the culture solution in the suspension solution is transferred to the hollow fibers of the unit. (ii) After that, the water is discharged from both ends or one end of the unit through the wall membrane to the outside of the culture tank through a conduit, and (ii)
An aqueous liquid medium that does not adversely affect the cell culture is supplied from outside the culture tank to both ends or one end of the unit through a conduit, and the liquid medium flows into the suspension liquid through the hollow fiber wall membrane, and the liquid medium is discharged. A cell culture method characterized by repeating alternating inflow and inflow. 2 At least two units are housed in the suspension liquid of a suspension-type cell culture tank, each unit is operated so that the discharge and inflow are alternately repeated, and the suspension in the culture tank is 2. The cell culture method according to claim 1, characterized in that the intervals between discharge and inflow of each unit are mutually controlled so that the discharge of the culture medium in the John's solution does not stop.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6112084A JPS60207581A (en) | 1984-03-30 | 1984-03-30 | Cell culture method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6112084A JPS60207581A (en) | 1984-03-30 | 1984-03-30 | Cell culture method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60207581A JPS60207581A (en) | 1985-10-19 |
| JPS6233878B2 true JPS6233878B2 (en) | 1987-07-23 |
Family
ID=13161895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6112084A Granted JPS60207581A (en) | 1984-03-30 | 1984-03-30 | Cell culture method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60207581A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3541738A1 (en) * | 1985-11-26 | 1987-05-27 | Boehringer Mannheim Gmbh | METHOD AND DEVICE FOR CULTIVATING CELLS |
-
1984
- 1984-03-30 JP JP6112084A patent/JPS60207581A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60207581A (en) | 1985-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1107211A (en) | Method for in vitro propagation and maintenance of cells | |
| CN107012072B (en) | Optical biomembrane reactor and application thereof in sewage treatment, carbon fixation and microalgae collection | |
| CA2678893C (en) | Methods to control cell movement in hollow fiber bioreactors | |
| CN104321419B (en) | Cell culture system and cell culture method | |
| JP2010523118A (en) | Improved bioreactor surface | |
| JPH09500818A (en) | Particle sedimentation tank used for cell culture | |
| JPH0363348B2 (en) | ||
| JP4668568B2 (en) | Culturing container, culturing apparatus, and cell culturing method | |
| CN105713827B (en) | A kind of nitrifying bacteria enrichment culture apparatus and cultural method | |
| AU778141B2 (en) | Method for cultivating cells, a membrane module, utilization of a membrane module and reaction system for cultivation of said cells | |
| JPS62130683A (en) | Method and apparatus for culturing cell | |
| JP3412364B2 (en) | Cell culture device and cell culture method | |
| JPS6233878B2 (en) | ||
| JPS63240774A (en) | bioreactor | |
| Blasey et al. | Strategies to increase the efficiency of membrane aerated and perfused animal cell bioreactors by an improved medium perfusion | |
| JPS6212990B2 (en) | ||
| JPH01222768A (en) | bioreactor | |
| JP2003180334A (en) | Module for three-dimensional high-density cell culture | |
| JP2675408B2 (en) | Hollow fiber membrane bioreactor | |
| JPS60259179A (en) | Cell culture tank and cell culture method | |
| JPS60156378A (en) | Culture medium of cell | |
| JPS6336774A (en) | Cell culture apparatus | |
| JPS6156075A (en) | Cultivation of human-human hybridoma | |
| JPS62138184A (en) | Apparatus for continuous culture of microorganism | |
| JPS61100191A (en) | Cell culture process |